Dr. Inge Winter: Clinical Trials

4 trials sponsored by Dr. Inge Winter, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 3 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 3
Phase 41Recruiting 1

Follow Dr. Inge Winter: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder
Phase 3RecruitingDr. Inge Winter12542025-04-272026-01-22
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Escitalopram, Sertraline, Venlafaxine - Bipolar Depression
Phase 3RecruitingDr. Inge Winter4182025-02-112025-09-26
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine hydrochloride - Major Depressive Disorder, Treatment Resistant Depression
Phase 3RecruitingDr. Inge Winter4182024-08-312025-09-26
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Clozapine, Second-line Antipsychotics (treatment as usual) - Schizophrenia and Related Disorders, Early Treatment-Resistance
Phase 4RecruitingDr. Inge Winter4182024-08-012025-09-26

Conditions studied

Bipolar Disorder (2)  ·  Depressive Disorder, Major (2)  ·  Schizophrenia (2)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Psychotic Disorders (1)

Interventions

Bupropion (2)  ·  Clozapine (2)  ·  Escitalopram (2)  ·  Ketamine (2)  ·  Lithium (2)  ·  Quetiapine Fumarate (2)  ·  Sertraline (2)  ·  Venlafaxine Hydrochloride (2)  ·  Therapeutics (1)

Countries

Austria (3)  ·  Germany (3)  ·  Italy (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Greece (2)  ·  Israel (1)

Results publications

PMID 41401709

NIH funding

2023 (3)